MetLife Investment Management’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $102K | Buy |
22,131
+245
| +1% | +$1.28K | ﹤0.01% | 2531 |
|
|
2025
Q4 | $109K | Sell |
21,886
-229
| -1% | -$1.19K | ﹤0.01% | 2564 |
|
|
2025
Q3 | $112K | Sell |
22,115
-3,238
| -13% | -$14.3K | ﹤0.01% | 2603 |
|
|
2025
Q2 | $109K | Sell |
25,353
-2,466
| -9% | -$12.2K | ﹤0.01% | 2500 |
|
|
2025
Q1 | $168K | Sell |
27,819
-237
| -0.8% | -$1.2K | ﹤0.01% | 2292 |
|
|
2024
Q4 | $111K | Sell |
28,056
-553
| -2% | -$2.48K | ﹤0.01% | 2574 |
|
|
2024
Q3 | $167K | Sell |
28,609
-351
| -1% | -$1.73K | ﹤0.01% | 2375 |
|
|
2024
Q2 | $125K | Buy |
28,960
+17,384
| +150% | +$83.3K | ﹤0.01% | 2488 |
|
|
2024
Q1 | $54.4K | Sell |
11,576
-326,077
| -97% | -$1.25M | ﹤0.01% | 2705 |
|
|
2023
Q4 | $1.66M | Sell |
337,653
-5,190
| -2% | -$25.4K | 0.01% | 1026 |
|
|
2023
Q3 | $1.87M | Sell |
342,843
-15,619
| -4% | -$125K | 0.01% | 930 |
|
|
2023
Q2 | $3.32M | Sell |
358,462
-8,735
| -2% | -$73.9K | 0.02% | 701 |
|
|
2023
Q1 | $3.02M | Sell |
367,197
-9,230
| -2% | -$102K | 0.02% | 731 |
|
|
2022
Q4 | $4.19M | Sell |
376,427
-8,157
| -2% | -$94.8K | 0.03% | 537 |
|
|
2022
Q3 | $4.56M | Sell |
384,584
-5,541
| -1% | -$83.9K | 0.04% | 454 |
|
|
2022
Q2 | $5.96M | Buy |
390,125
+4,266
| +1% | +$76.8K | 0.05% | 341 |
|
|
2022
Q1 | $8.16M | Buy |
385,859
+96,885
| +34% | +$2.09M | 0.05% | 304 |
|
|
2021
Q4 | $6.83M | Buy |
288,974
+2,795
| +1% | +$59.9K | 0.06% | 287 |
|
|
2021
Q3 | $5.74M | Sell |
286,179
-7,730
| -3% | -$158K | 0.05% | 311 |
|
|
2021
Q2 | $5.91M | Sell |
293,909
-5,684
| -2% | -$122K | 0.05% | 320 |
|
|
2021
Q1 | $6.38M | Buy |
299,593
+6,288
| +2% | +$135K | 0.06% | 295 |
|
|
2020
Q4 | $6.39M | Sell |
293,305
-9,471
| -3% | -$185K | 0.06% | 290 |
|
|
2020
Q3 | $5.34M | Sell |
302,776
-10,975
| -3% | -$204K | 0.06% | 302 |
|
|
2020
Q2 | $5.9M | Buy |
313,751
+16,735
| +6% | +$296K | 0.07% | 257 |
|
|
2020
Q1 | $5.14M | Hold |
297,016
| – | – | 0.07% | 240 |
|
|
2019
Q4 | $6.27M | Buy |
297,016
+37,440
| +14% | +$758K | 0.07% | 267 |
|
|
2019
Q3 | $5.08M | Buy |
259,576
+25,895
| +11% | +$476K | 0.06% | 325 |
|
|
2019
Q2 | $4.08M | Buy |
233,681
+1,399
| +0.6% | +$25.2K | 0.04% | 452 |
|
|
2019
Q1 | $4.3M | Buy |
232,282
+9,756
| +4% | +$174K | 0.05% | 406 |
|
|
2018
Q4 | $3.58M | Sell |
222,526
-850
| -0.4% | -$13.4K | 0.04% | 431 |
|
|
2018
Q3 | $3.33M | Sell |
223,376
-5,861
| -3% | -$85.5K | 0.03% | 600 |
|
|
2018
Q2 | $3.22M | Buy |
229,237
+1,647
| +0.7% | +$21.8K | 0.04% | 559 |
|
|
2018
Q1 | $2.96M | Sell |
227,590
-2,815
| -1% | -$36K | 0.03% | 620 |
|
|
2017
Q4 | $3.17M | Buy |
+230,405
| New | +$3.11M | 0.04% | 608 |
|
Other funds holding MPT
VPM
VCM
WAM
MetLife Investment Management's MPT Position: Q1 2026 in Review
MetLife Investment Management increased its Medical Properties Trust (MPT) stake by 1.1% in Q1 2026, buying an estimated $1.28K and bringing the position to 22,131 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2531.
MetLife Investment Management first reported a position in MPT in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.16M in Q1 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.
- MetLife Investment Management held 22,131 shares of Medical Properties Trust worth $102K as of Q1 2026.
- MetLife Investment Management bought 245 Medical Properties Trust shares in Q1 2026, an estimated $1.28K.
- Medical Properties Trust made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2531 holding.
- MetLife Investment Management first reported a position in Medical Properties Trust in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Medical Properties Trust position peaked at $8.16M in Q1 2022.
- 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.